Report overview
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Drug Delivery Equipment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Drug Delivery Equipment. This report contains market size and forecasts of Subcutaneous Drug Delivery Equipment in global, including the following market information:
Global Subcutaneous Drug Delivery Equipment Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Subcutaneous Drug Delivery Equipment Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Subcutaneous Drug Delivery Equipment companies in 2022 (%)
The global Subcutaneous Drug Delivery Equipment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Syringe Based Subcutaneous Drug Delivery Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Subcutaneous Drug Delivery Equipment include Boehringer Ingelheim, Eli Lily, Galaxo, HMD pharmaceuticals, Merck, Novartis, Novo Nordisk, Pfizer and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Subcutaneous Drug Delivery Equipment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Subcutaneous Drug Delivery Equipment Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Subcutaneous Drug Delivery Equipment Market Segment Percentages, by Type, 2022 (%)
Syringe Based Subcutaneous Drug Delivery
Subcutaneous Implants
Pen Systems for Subcutaneous Drug Delivery
Auto Injectors
Pump Based Drug Delivery Systems
Global Subcutaneous Drug Delivery Equipment Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Subcutaneous Drug Delivery Equipment Market Segment Percentages, by Application, 2022 (%)
In-Patient
Out-Patient
Clinic
Others
Global Subcutaneous Drug Delivery Equipment Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Subcutaneous Drug Delivery Equipment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Subcutaneous Drug Delivery Equipment revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Subcutaneous Drug Delivery Equipment revenues share in global market, 2022 (%)
Key companies Subcutaneous Drug Delivery Equipment sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Subcutaneous Drug Delivery Equipment sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim
Eli Lily
Galaxo
HMD pharmaceuticals
Merck
Novartis
Novo Nordisk
Pfizer
Sanofi
Teva Pharmaceutical
Zogenix
Outline of Major Chapters:
Chapter 1: Introduces the definition of Subcutaneous Drug Delivery Equipment, market overview.
Chapter 2: Global Subcutaneous Drug Delivery Equipment market size in revenue and volume.
Chapter 3: Detailed analysis of Subcutaneous Drug Delivery Equipment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Subcutaneous Drug Delivery Equipment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Subcutaneous Drug Delivery Equipment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
